Coronavirus vaccine can bring profit and public health collide their countries interest. What will be the size of distribution and market value for the product? Shall there a monopoly in a distribution system?
This is depend upon the economical policy of that country, who will make corona vaccine successfully.
For uniformly distribution, UN and other Big organization should come forward to consider the distribution of corona vaccine as a mankind work.
For this,
We have to share vaccine formula and setup laboratory in every infected country or group of country and make vaccine with the help of local scientist.
We also need a data of infected persons with the distribution among More serious, serious or primary stage because this data will provide us targets.
For Uniformly distribution, we also need to setup Corona Commission (At every stage- International -> continental-> Sub-Continental -> Country-> State-> District-> City-> Village.). We have to make a transparent and safe administrative bodies from higher to lower.
This is depend upon the economical policy of that country, who will make corona vaccine successfully.
For uniformly distribution, UN and other Big organization should come forward to consider the distribution of corona vaccine as a mankind work.
For this,
We have to share vaccine formula and setup laboratory in every infected country or group of country and make vaccine with the help of local scientist.
We also need a data of infected persons with the distribution among More serious, serious or primary stage because this data will provide us targets.
For Uniformly distribution, we also need to setup Corona Commission (At every stage- International -> continental-> Sub-Continental -> Country-> State-> District-> City-> Village.). We have to make a transparent and safe administrative bodies from higher to lower.
Distribution is not likely to be easy for world; viz for nations too.
Distribution is going to be another challenge, particularly when it comes to the last mile. A vaccine would need to reach all corners of the world in order to effectively tackle the virus. We know the case of year 1920, how India survived to develop the vaccines and it got successful only after the loss of 17 million peoples.
“Global problem that requires a global solution,”. “We need the best biological, molecular, cell, protein and virology science in the world. We need the best manufacturing in the world. Industries from around the world need to engage on one platform to uniform distribute. Industrialists and politician might be in the same race to grab first who sells and what money pay for it? If we have anybody left over anywhere as a reservoir of virus, it not only threatens them, but threatens the world.
People of all ages can be infected by the new corona virus (COVID19). Older people and people with pre-existing medical conditions (such as obesity, asthma, diabetes, and heart disease) appear to be more vulnerable to becoming severely ill with the virus. There are multiple teams working on a corona virus vaccine, with the hope that several could be approved in record speed. Billions of doses will need to be manufactured, meaning collaboration between industry, regulators and the scientific community will be crucial. The vaccine needs to be available in all parts of the world to ensure that a reservoir of the virus does not remain. Researchers around the world are working against the clock to create a vaccine to halt the spread of corona virus. Anyway, researchers around the world are working against the clock to create a vaccine to halt the spread of corona virus.
But, company engaged in innovation, if one county developed first, they will have patent priority right or monopoly on the developed vaccine to sell up I market. So, big question is there, whether it is reachable within the limit to all sections of society or will avail to the society whp can bear the money for the same.
I agree with Ashish Thakur and Vidit Pandey that it is a global problem needing a global solution. I don't think there has ever been anything comparable. I don't think it is in the best interest of a country that does produce an effective vaccine to keep the monopoly and market it. Again, as Ashish Thakur wrote, above, it is a global problem and it requires a global solution. It would not be in the interest of any one country to exclude those who could not afford to purchase because of market forces. The countries not able to vaccinate could become reservoirs of infection and a danger countries that were in the process of organising a program of vaccination.
Hopefully, such a program would target health workers, key workers and those who are vulnerable, first.
True. WHO and UN can not force country for uniformity of distribution throughout the world. Missing Global coordination(China, Europe, Aisa, USA) to extant, it seems very difficult for world market to distribute on same platform with appropriate price of vaccination throughout the world poor or rich country..
UN can not force any country for trading policies for uniformally distribution of vaccine. But UN can suggest for making better discipline and that country (who will go distribute corona vaccine) must consider it as a moral work. UN and other organisation can help poor country ecconomically to purchase the vaccine.
As above there is an economic and a moral side to this. If there are many distributors and vaccines available, then countries are likely to vaccinate their own population and then make it available to other countries. If companies decide to patent the vaccine, then this becomes much harder as cheaper versions cannot be made. Many countries, for example the UK, are looking to make enough for their own population and similar amounts to provide through aid channels. This is one way that the problem may be solved, if this approach is taken by many countries and the UN/WHO itself. This all relies on a vaccine being successful and research into how long immunity will last. If vaccines are needed for the whole population on 3 month or yearly basis, this will make it a lot harder.